【结 构 式】 |
【分子编号】36261 【品名】(2R)-8-(4-methyl-1-piperazinyl)-1,2,3,4-tetrahydro-2-naphthalenamine; (2R)-8-(4-methyl-1-piperazinyl)-1,2,3,4-tetrahydro-2-naphthalenylamine 【CA登记号】 |
【 分 子 式 】C15H23N3 【 分 子 量 】245.36784 【元素组成】C 73.43% H 9.45% N 17.13% |
合成路线1
该中间体在本合成路线中的序号:(XI)The alkylation of (R)-2-amino-8-methoxy-1,2,3,4-tetrahydronaphthalene (I) with benzyl bromide provided the corresponding dibenzyl amine (II). After conversion of (II) to the hydrochloride salt, methyl ether cleavage by means of BBr3 at low temperature gave rise to naphthol (III). Condensation of (III) with 2-bromoisobutyramide (IV) yielded the naphthyloxybutyramide (V), which was rearranged at 130 C in the presence of NaH to the N-naphthyl-2-hydroxybutyramide (VI). Acid hydrolysis of the amide function of (VI) gave diamine (VII). This was condensed with N-methyl iminodiacetic acid (VIII) using CDI in boiling THF to produce the piperazinedione (IX). After reduction of (IX) to the corresponding piperazine (X) with LiAlH4, the N-benzyl groups were cleaved by hydrogenolysis over Pd/C to afford the primary amine (XI). Finally, coupling of (XI) with 4-mo-pholinobenzoic (XII) acid using CDI provided the title amide.
【1】 Berg, S.; Florvall, L.; Ross, S.; Thorberg, S.-O. (AstraZeneca plc); Substd. 1,2,3,4-tetrahydronaphthalene derivs.. EP 0888319; JP 2000506883; US 6124283; WO 9734883 . |
【2】 Thorberg, S.-O.; Ross, S.; Berg, S. (AstraZeneca plc); A combination of a selective 5-HT1A antagonist and a selective h5-HT1B antagonist or partial agonist. WO 9913876 . |
【3】 Berg, S.; Ross, S.; Thorberg, S.-O. (AstraZeneca AB); A Combination of a 5-HT reuptake inhibitor and a H5-HT1B antagonist or partial agonist. AU 9193098; EP 1014985; WO 9913877 . |
【4】 Berg, S.; Ross, S.; Thorberg, S.-O. (AstraZeneca AB); A combination of a monoamine oxidase inhibitor and a H5-HT1B antagonist or partial agonist. AU 9193198; EP 1014986; WO 9913878 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
12912 | 1-(Bromomethyl)benzene; Alpha-bromotoluene | 100-39-0 | C7H7Br | 详情 | 详情 | |
(I) | 36251 | (2R)-8-methoxy-1,2,3,4-tetrahydro-2-naphthalenylamine; (2R)-8-methoxy-1,2,3,4-tetrahydro-2-naphthalenamine | C11H15NO | 详情 | 详情 | |
(II) | 36252 | N,N-dibenzyl-N-[(2R)-8-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]amine; (2R)-N,N-dibenzyl-8-methoxy-1,2,3,4-tetrahydro-2-naphthalenamine | C25H27NO | 详情 | 详情 | |
(III) | 36253 | (7R)-7-(dibenzylamino)-5,6,7,8-tetrahydro-1-naphthalenol | C24H25NO | 详情 | 详情 | |
(IV) | 36254 | 2-bromo-2-methylpropanamide | C4H8BrNO | 详情 | 详情 | |
(V) | 36255 | 2-[[(7R)-7-(dibenzylamino)-5,6,7,8-tetrahydro-1-naphthalenyl]oxy]-2-methylpropanamide | C28H32N2O2 | 详情 | 详情 | |
(VI) | 36256 | N-[(7R)-7-(dibenzylamino)-5,6,7,8-tetrahydro-1-naphthalenyl]-2-hydroxy-2-methylpropanamide | C28H32N2O2 | 详情 | 详情 | |
(VII) | 36257 | (7R)-N(7),N(7)-dibenzyl-5,6,7,8-tetrahydro-1,7-naphthalenediamine; N-[(2R)-8-amino-1,2,3,4-tetrahydro-2-naphthalenyl]-N,N-dibenzylamine | C24H26N2 | 详情 | 详情 | |
(VIII) | 36258 | 2-[(carboxymethyl)(methyl)amino]acetic acid | 4408-64-4 | C5H9NO4 | 详情 | 详情 |
(IX) | 36259 | 1-[(7R)-7-(dibenzylamino)-5,6,7,8-tetrahydro-1-naphthalenyl]-4-methyl-2,6-piperazinedione | C29H31N3O2 | 详情 | 详情 | |
(X) | 36260 | (2R)-N,N-dibenzyl-8-(4-methyl-1-piperazinyl)-1,2,3,4-tetrahydro-2-naphthalenamine; N,N-dibenzyl-N-[(2R)-8-(4-methyl-1-piperazinyl)-1,2,3,4-tetrahydro-2-naphthalenyl]amine | C29H35N3 | 详情 | 详情 | |
(XI) | 36261 | (2R)-8-(4-methyl-1-piperazinyl)-1,2,3,4-tetrahydro-2-naphthalenamine; (2R)-8-(4-methyl-1-piperazinyl)-1,2,3,4-tetrahydro-2-naphthalenylamine | C15H23N3 | 详情 | 详情 | |
(XII) | 36262 | 4-(4-morpholinyl)benzoic acid | C11H13NO3 | 详情 | 详情 |